JP2001517693A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001517693A5 JP2001517693A5 JP2000513564A JP2000513564A JP2001517693A5 JP 2001517693 A5 JP2001517693 A5 JP 2001517693A5 JP 2000513564 A JP2000513564 A JP 2000513564A JP 2000513564 A JP2000513564 A JP 2000513564A JP 2001517693 A5 JP2001517693 A5 JP 2001517693A5
- Authority
- JP
- Japan
- Prior art keywords
- mlcvs
- biologically active
- active ingredient
- vesicles
- luvs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000004480 active ingredient Substances 0.000 description 20
- 241001411492 Melon leaf curl virus Species 0.000 description 19
- 238000000034 method Methods 0.000 description 17
- 230000018044 dehydration Effects 0.000 description 5
- 238000006297 dehydration reaction Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000003960 organic solvent Substances 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 4
- 239000002502 liposome Substances 0.000 description 4
- 108090000695 Cytokines Proteins 0.000 description 3
- 102000004127 Cytokines Human genes 0.000 description 3
- 102000000588 Interleukin-2 Human genes 0.000 description 2
- 108010002350 Interleukin-2 Proteins 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000002691 unilamellar liposome Substances 0.000 description 2
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000012062 aqueous buffer Substances 0.000 description 1
- 238000004581 coalescence Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 230000000887 hydrating effect Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6060697P | 1997-10-01 | 1997-10-01 | |
| US60/060,606 | 1997-10-01 | ||
| PCT/US1998/020780 WO1999016426A2 (en) | 1997-10-01 | 1998-10-01 | Multilamellar coalescence vesicles (mlcv) containing biologically active compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001517693A JP2001517693A (ja) | 2001-10-09 |
| JP2001517693A5 true JP2001517693A5 (enExample) | 2006-01-05 |
Family
ID=22030591
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000513564A Pending JP2001517693A (ja) | 1997-10-01 | 1998-10-01 | 生物学的活性成分を含有する多層板状合着小胞（ｍｌｃｖ） |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6544549B1 (enExample) |
| EP (1) | EP1019026B1 (enExample) |
| JP (1) | JP2001517693A (enExample) |
| AT (1) | ATE286717T1 (enExample) |
| AU (1) | AU745000B2 (enExample) |
| CA (1) | CA2305533C (enExample) |
| DE (1) | DE69828624T2 (enExample) |
| IN (1) | IN190388B (enExample) |
| WO (1) | WO1999016426A2 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080102111A1 (en) * | 2005-03-09 | 2008-05-01 | Hiromichi Imanaka | Anticancer Composition for Oral Use Comprising Liposome Containing Phytosterols and Prevention or Treatment for Cancer Using the Liposome |
| US7662405B2 (en) * | 2005-08-09 | 2010-02-16 | The Research Foundation Of State University Of New York | Compositions and methods of preparation of liposomal microparticulate IL-12 |
| US20140271782A1 (en) | 2013-03-15 | 2014-09-18 | Dermazone Solutions, Inc. | Method for preparing nanolipids with encapsulated alcohol |
| EP3219307B1 (en) * | 2005-12-30 | 2021-09-08 | NuVessl Inc. | Nanolipidic particles |
| US9283184B2 (en) | 2008-11-24 | 2016-03-15 | Massachusetts Institute Of Technology | Methods and compositions for localized agent delivery |
| US20100323018A1 (en) * | 2009-06-17 | 2010-12-23 | Massachusetts Institute Of Technology | Branched DNA/RNA monomers and uses thereof |
| US20100324124A1 (en) * | 2009-06-17 | 2010-12-23 | Massachusetts Institute Of Technology | Compositions and methods relating to DNA-based particles |
| US9149432B2 (en) | 2010-03-19 | 2015-10-06 | Massachusetts Institute Of Technology | Lipid vesicle compositions and methods of use |
| MX2012010810A (es) * | 2010-03-19 | 2013-02-07 | Massachusetts Inst Technology | Composiciones de vesícula de lípido y métodos de uso. |
| US20110229556A1 (en) * | 2010-03-19 | 2011-09-22 | Massachusetts Institute Of Technology | Lipid-coated polymer particles for immune stimulation |
| CN102654505A (zh) * | 2012-05-16 | 2012-09-05 | 江苏省原子医学研究所 | 一种检测il-2-hsa的时间分辨荧光免疫分析试剂盒及其检测方法 |
| ES2641375T3 (es) * | 2012-11-02 | 2017-11-08 | Cytuvax | Composición que comprende macroagregados de citoquinas |
| US9770415B2 (en) * | 2012-11-27 | 2017-09-26 | Southwest Research Institute | Delivery substrates from aligned polymer biomaterials for tissue repair |
| EP4043036A1 (en) | 2013-09-27 | 2022-08-17 | Massachusetts Institute of Technology | Carrier-free biologically-active protein nanostructures |
| DK3291797T3 (da) | 2015-05-04 | 2020-09-21 | Versantis AG | Metode til forberedelse af transmembran ph-gradiente vesikler |
| US11034752B2 (en) | 2015-08-12 | 2021-06-15 | Massachusetts Institute Of Technology | Cell surface coupling of nanoparticles |
| JP7185530B2 (ja) | 2016-06-13 | 2022-12-07 | トルク セラピューティクス， インコーポレイテッド | 免疫細胞機能を促進するための方法および組成物 |
| CA3074826A1 (en) | 2017-09-05 | 2019-03-14 | Torque Therapeutics, Inc. | Therapeutic protein compositions and methods of making and using the same |
| US20200078316A1 (en) | 2018-09-06 | 2020-03-12 | NuVessl, Inc. | Method of Using Cannabinoids Encapsulated in Phospholipid Carriers for Transmucosal and Transdermal Administration |
| US11458092B2 (en) | 2018-12-14 | 2022-10-04 | NuVessl, Inc. | Composition with enhanced passenger molecule loading |
| EP4099988A4 (en) * | 2020-02-05 | 2024-03-13 | University of Florida Research Foundation, Incorporated | Rna-loaded nanoparticles and use thereof for the treatment of cancer |
| EP4209586B1 (en) * | 2020-09-04 | 2025-10-29 | Daegu Gyeongbuk Institute Of Science and Technology | Extracellular vesicle expressing cytokine and antibody, method for producing same, and use thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04356421A (ja) | 1991-03-06 | 1992-12-10 | Green Cross Corp:The | プロスタグランジン類含有脂肪小体組成物 |
| US6312718B1 (en) * | 1996-02-16 | 2001-11-06 | Biomira Usa, Inc. | Vaccine for B-cell malignancies |
-
1998
- 1998-01-01 IN IN2930DE1998 patent/IN190388B/en unknown
- 1998-10-01 AT AT98950869T patent/ATE286717T1/de not_active IP Right Cessation
- 1998-10-01 EP EP98950869A patent/EP1019026B1/en not_active Expired - Lifetime
- 1998-10-01 US US09/164,350 patent/US6544549B1/en not_active Expired - Lifetime
- 1998-10-01 DE DE69828624T patent/DE69828624T2/de not_active Expired - Lifetime
- 1998-10-01 WO PCT/US1998/020780 patent/WO1999016426A2/en not_active Ceased
- 1998-10-01 AU AU96800/98A patent/AU745000B2/en not_active Ceased
- 1998-10-01 CA CA002305533A patent/CA2305533C/en not_active Expired - Fee Related
- 1998-10-01 JP JP2000513564A patent/JP2001517693A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2001517693A5 (enExample) | ||
| CA2305533A1 (en) | Multilamellar coalescence vesicles (mlcv) containing biologically active compounds | |
| CA1315678C (en) | Alpha-tocopherol based vesicles | |
| CA2078666C (en) | Heterovesicular liposomes | |
| KR100387561B1 (ko) | 활성제제의조절방출을위한다중소포성리포솜의제법 | |
| US5234634A (en) | Method for preparing alpha-tocopherol vesicles | |
| EP0158441B2 (en) | Liposome-forming composition | |
| CA1154674A (en) | Process for making lipid membrane structure | |
| JP3411570B2 (ja) | ブレンドした脂質小胞 | |
| JP4497765B2 (ja) | 自己形成する熱力学的安定なリポソームおよびその適用 | |
| CA2259179C (en) | Emulsion formulations for hydrophilic active agents | |
| EP0177223B1 (en) | Pharmaceutical multi-phase composition | |
| JP3836874B2 (ja) | 免疫アジュバントとして少ラメラ脂質小胞を含むワクチン | |
| WO1996040061A1 (en) | Method for encapsulating pharmaceutical materials | |
| JPH07241487A (ja) | プロリポソーム及びリポソームの製造方法 | |
| US7476400B2 (en) | High-concentration lidocaine compositions and methods for their preparation | |
| TWI250877B (en) | Process for producing liposome suspensions and products containing liposome suspensions produced thereby | |
| AU2002352662A1 (en) | High-concentration lidocaine compositions and methods for their preparation |